Trial intelligence / Profile preview

Timing of corticosteroid therapy in hospitalized adults with COVID-19

ChiCTR2000030481Phase 4Recruiting

Sponsor
Zhongnan Hospital of Wuhan University
Start
Mar 2020
Countries
1
01

Overview

Phase 4, randomised, open-label trial of corticosteroids in coronavirus disease 2019 (COVID-19) (3 arms), sponsored by Zhongnan Hospital of Wuhan University. Primary endpoint: Time to negative SARS-CoV-2 RT-PCR. Started Mar 2020; status: recruiting.

02

Drugs

corticosteroids
03

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on ChiCTR2000030481.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000030481.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call